glutathione and triple negative breast cancer Glutathione-depleting self-immolative nanoparticles boost cuproptosis-driven metalloimmunotherapy for triple- A review of biological targets
A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect Metabolic interplay between exogenous cystine and glutamine dependence in triple negative breast cancer Cell Death Discovery Targeting the redox programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Cell Death Discovery Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect Ratiometrically designed nanoprodrug for triple negative breast cancer treatment
Pay in 4 interest-free payments of $5.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 17 - Sep 22




